Screening and management of hyperlipidemia in children

Pediatric Annals

Volumn 29, Issue 8, 2000, Pages 500-508

  McCrindle, B W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ASCORBIC ACID; BEZAFIBRATE; COLESTIPOL; COLESTYRAMINE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; PROBUCOL; SIMVASTATIN;

ATHEROSCLEROSIS; DIAGNOSTIC PROCEDURE; DIET THERAPY; DISEASE ASSOCIATION; DRUG INDICATION; DRUG INDUCED DISEASE; HUMAN; HYPERLIPIDEMIA; ONSET AGE; PRACTICE GUIDELINE; REVIEW; TREATMENT PLANNING;

EID: 0033874107     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20000801-09     Document Type: Review

References (40)

1. Is there an epidemic of cardiovascular disease on the horizon?
2. Tracking of blood lipids and blood pressures in school age children: The Muscatine study
3. Precursors of cardiovascular risk in young adults from a biracial (black-white) population: The Bogalusa Heart Study
4. Effects of secular trends in obesity on coronary risk factors in children: The Bogalusa Heart Study
5. Secular increases in relative weight and adiposity among children over two decades: The Bogalusa Heart Study
6. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents, and young adults: The Bogalusa Heart Study
7. Endothelial dysfunction: Does it matter? Is it reversible?
8. Assessment and treatment of endothelial dysfunction in humans
9. Rationale to study the early natural history of heart disease: The Bogalusa Heart Study
10. Secular trends in dietary intakes and cardiovascular risk factors of 10-y-old children: The Bogalusa Heart Study (1973-1988)
11. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: The Bogalusa Heart Study
12. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study
13. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
14. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study
15. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
16. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease
17. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level
18. Increased intimamedia thickness of the common carotid artery in hypercholesterolemic children
19. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects
20. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The Muscatine Study
21. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
22. Problems with the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
23. Challenges to implementing the current pediatric cholesterol screening guidelines into practice
24. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: The Dietary Intervention Study in Children (DISC)
25. Cardiovascular disease risk factors in young children in the STRIP baby project: Special Turku Coronary Risk Factor Intervention Project for Children
26. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
27. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial
28. Colestipol tablets in adolescents with familial hypercholesterolaemia
29. Simvastatin use in children
30. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia
31. Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin: Canadian Lovastatin in Children Study Group
32. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: A randomized controlled trial
33. Double blind trial of bezafibrate in familial hypercholesterolaemia
34. Niacin treatment of hypercholesterolemia in children
35. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: Improvement with antioxidant vitamin therapy
36. Garlic extract therapy in children with hypercholesterolemia
37. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia
38. Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: The STRIP project
39. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia
40. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: A controlled, double-blind, crossover study